Close Menu

NEW YORK (360Dx) – Numares confirmed on Wednesday that its test for diagnosing kidney rejection has received CE-IVD marking. The firm has launched it in Europe.

Called renalTX-Score, the test is the first to be available worldwide that evaluates a metabolic biomarker network, rather than single biomarkers or tissue biopsy for diagnosing acute rejection following a kidney transplant, Numares said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.